Mochida Pharmaceutical Co., Ltd. (4534.T)
JPY 3460.0
(0.29%)
JPY 3460.0
(0.29%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.48 Billion | 7.29 Billion | 7.45 Billion | 9.19 Billion | 9.34 Billion | 12.56 Billion |
| Net Income | 4.54 Billion | 9.04 Billion | 14.59 Billion | 11.9 Billion | 6.27 Billion | 11.64 Billion |
| Depreciation & Amortization | 2.8 Billion | 2.67 Billion | 2.68 Billion | 2.74 Billion | 2.73 Billion | 2.91 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -15.14 Billion | 2.17 Billion | -3.52 Billion | -2.3 Billion | -125 Million | 2.36 Billion |
| Other non-cash items | 16.6 Billion | -6.59 Billion | -6.29 Billion | -3.13 Billion | 468 Million | -4.35 Billion |
| Investing Cash Flow | 74 Million | -2.94 Billion | -2 Billion | -880 Million | -1.76 Billion | -1.12 Billion |
| Investments in PPE | -2.29 Billion | -2.16 Billion | -3.09 Billion | -2.08 Billion | -1.95 Billion | -1.36 Billion |
| Acquisitions | 56 Million | - | - | 204 Million | 185 Million | - |
| Investment purchases | -22.8 Billion | -22.5 Billion | -21.94 Billion | -22.5 Billion | -23.5 Billion | -23.5 Billion |
| Sales/Maturities of investments | 25.1 Billion | 21.4 Billion | 23.03 Billion | 23.5 Billion | 23.5 Billion | 23.96 Billion |
| Other Investing Activities | 11 Million | 317 Million | -9 Million | 4 Million | 6 Million | -216 Million |
| Financing Cash Flow | -6.39 Billion | -6.88 Billion | -5.95 Billion | -5.11 Billion | -5.32 Billion | -6.09 Billion |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -2.88 Billion | -3.37 Billion | -3.44 Billion | -3.1 Billion | -3.33 Billion | -3.52 Billion |
| Common Stock Repurchased | -3.49 Billion | -3.51 Billion | -2.51 Billion | -2 Billion | -1.99 Billion | -2.52 Billion |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -14 Million | -3.51 Billion | -2.51 Billion | -1 Million | -1.99 Billion | -46 Million |
| Accounts receivables | -7.03 Billion | 3.86 Billion | -2.48 Billion | -740 Million | 890 Million | 2.42 Billion |
| Accounts payables | 2.22 Billion | -1.94 Billion | 2.17 Billion | -3.93 Billion | 192 Million | -3.03 Billion |
| Inventory | -5.87 Billion | -1.27 Billion | -521 Million | 2.46 Billion | -428 Million | 362 Million |
| Other working capital | -4.46 Billion | 1.52 Billion | -2.69 Billion | -98 Million | -779 Million | 2.6 Billion |
| Cash at beginning of period | 24.51 Billion | 40.51 Billion | 40.98 Billion | 37.79 Billion | 35.53 Billion | 30.18 Billion |
| Cash at end of period | 33.29 Billion | 38.01 Billion | 40.51 Billion | 40.98 Billion | 37.79 Billion | 35.53 Billion |
| Capital Expenditure | -2.29 Billion | -2.16 Billion | -3.09 Billion | -2.08 Billion | -1.95 Billion | -1.36 Billion |
| Effect of forex changes on cash | 79 Million | 32 Million | 31 Million | -9 Million | - | - |
| Net cash flow / Change in cash | 8.78 Billion | -2.5 Billion | -472 Million | 3.19 Billion | 2.25 Billion | 5.35 Billion |
| Free Cash Flow | -9.77 Billion | 5.13 Billion | 4.36 Billion | 7.11 Billion | 7.38 Billion | 11.19 Billion |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.55 Billion | 4.54 Billion | 103 Million | 1.6 Billion | 1.15 Billion | 1.68 Billion |
| Depreciation & Amortization | - | 2.8 Billion | - | 728 Million | 665 Million | 643 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -15.14 Billion | - | - | -3.47 Billion | - |
| Other non-cash items | -1.55 Billion | 16.6 Billion | -103 Million | -1.6 Billion | -1.15 Billion | -1.68 Billion |
| Investing Cash Flow | - | 74 Million | - | - | -895 Million | - |
| Investments in PPE | - | -2.29 Billion | - | - | -860.5 Million | - |
| Acquisitions | - | 56 Million | - | - | - | - |
| Investment purchases | - | -22.8 Billion | - | - | - | - |
| Sales/Maturities of investments | - | 25.1 Billion | - | - | - | - |
| Other Investing Activities | - | 11 Million | - | - | -34.5 Million | - |
| Financing Cash Flow | - | -6.39 Billion | - | - | -2.19 Billion | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | -2.88 Billion | - | - | - | - |
| Common Stock Repurchased | - | -3.49 Billion | - | - | -1.46 Billion | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -14 Million | - | - | -1.46 Billion | - |
| Accounts receivables | - | -7.03 Billion | - | - | -1.73 Billion | - |
| Accounts payables | - | 2.22 Billion | - | - | - | - |
| Inventory | - | -5.87 Billion | - | - | -1.74 Billion | - |
| Other working capital | - | -4.46 Billion | - | - | - | - |
| Cash at beginning of period | - | 24.51 Billion | - | 34.75 Billion | 55.51 Billion | 24.51 Billion |
| Cash at end of period | - | 33.29 Billion | - | 29.9 Billion | 34.75 Billion | 55.51 Billion |
| Capital Expenditure | - | -2.29 Billion | - | - | -860.5 Million | - |
| Effect of forex changes on cash | - | 79 Million | - | - | 33.5 Million | - |
| Net cash flow / Change in cash | - | 8.78 Billion | - | -4.84 Billion | -20.75 Billion | 31 Billion |
| Free Cash Flow | - | -9.77 Billion | - | 1.45 Billion | -3.82 Billion | 1.28 Billion |
RHIM
EDTXF
SPOK
ALIT
RCM
6794